Taiwan · Delayed Price · Currency is TWD GeneFerm Biotechnology Statistics
Total Valuation
TPEX:1796 has a market cap or net worth of TWD 1.64 billion. The enterprise value is 1.68 billion.
| Market Cap | 1.64B |
| Enterprise Value | 1.68B |
Important Dates
The next estimated earnings date is Monday, May 11, 2026.
| Earnings Date | May 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:1796 has 41.46 million shares outstanding. The number of shares has increased by 0.11% in one year.
| Current Share Class | 41.46M |
| Shares Outstanding | 41.46M |
| Shares Change (YoY) | +0.11% |
| Shares Change (QoQ) | +0.28% |
| Owned by Insiders (%) | 9.52% |
| Owned by Institutions (%) | n/a |
| Float | 20.67M |
Valuation Ratios
The trailing PE ratio is 56.81.
| PE Ratio | 56.81 |
| Forward PE | n/a |
| PS Ratio | 2.42 |
| PB Ratio | 2.01 |
| P/TBV Ratio | 2.01 |
| P/FCF Ratio | 21.61 |
| P/OCF Ratio | 16.51 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.97, with an EV/FCF ratio of 22.19.
| EV / Earnings | 58.34 |
| EV / Sales | 2.49 |
| EV / EBITDA | 13.97 |
| EV / EBIT | 36.54 |
| EV / FCF | 22.19 |
Financial Position
The company has a current ratio of 3.75, with a Debt / Equity ratio of 0.40.
| Current Ratio | 3.75 |
| Quick Ratio | 2.48 |
| Debt / Equity | 0.40 |
| Debt / EBITDA | 2.69 |
| Debt / FCF | 4.27 |
| Interest Coverage | 7.41 |
Financial Efficiency
Return on equity (ROE) is 3.60% and return on invested capital (ROIC) is 4.47%.
| Return on Equity (ROE) | 3.60% |
| Return on Assets (ROA) | 2.37% |
| Return on Invested Capital (ROIC) | 4.47% |
| Return on Capital Employed (ROCE) | 4.11% |
| Weighted Average Cost of Capital (WACC) | 3.84% |
| Revenue Per Employee | 4.70M |
| Profits Per Employee | 200,431 |
| Employee Count | 144 |
| Asset Turnover | 0.56 |
| Inventory Turnover | 2.73 |
Taxes
In the past 12 months, TPEX:1796 has paid 5.83 million in taxes.
| Income Tax | 5.83M |
| Effective Tax Rate | 16.81% |
Stock Price Statistics
The stock price has decreased by -15.85% in the last 52 weeks. The beta is 0.01, so TPEX:1796's price volatility has been lower than the market average.
| Beta (5Y) | 0.01 |
| 52-Week Price Change | -15.85% |
| 50-Day Moving Average | 40.87 |
| 200-Day Moving Average | 47.19 |
| Relative Strength Index (RSI) | 50.26 |
| Average Volume (20 Days) | 33,972 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:1796 had revenue of TWD 677.10 million and earned 28.86 million in profits. Earnings per share was 0.70.
| Revenue | 677.10M |
| Gross Profit | 190.80M |
| Operating Income | 46.08M |
| Pretax Income | 34.70M |
| Net Income | 28.86M |
| EBITDA | 113.48M |
| EBIT | 46.08M |
| Earnings Per Share (EPS) | 0.70 |
Balance Sheet
The company has 280.26 million in cash and 324.23 million in debt, with a net cash position of -43.97 million or -1.06 per share.
| Cash & Cash Equivalents | 280.26M |
| Total Debt | 324.23M |
| Net Cash | -43.97M |
| Net Cash Per Share | -1.06 |
| Equity (Book Value) | 816.66M |
| Book Value Per Share | 19.70 |
| Working Capital | 436.85M |
Cash Flow
In the last 12 months, operating cash flow was 99.31 million and capital expenditures -23.42 million, giving a free cash flow of 75.89 million.
| Operating Cash Flow | 99.31M |
| Capital Expenditures | -23.42M |
| Depreciation & Amortization | 67.41M |
| Net Borrowing | 81.06M |
| Free Cash Flow | 75.89M |
| FCF Per Share | 1.83 |
Margins
Gross margin is 28.18%, with operating and profit margins of 6.81% and 4.26%.
| Gross Margin | 28.18% |
| Operating Margin | 6.81% |
| Pretax Margin | 5.12% |
| Profit Margin | 4.26% |
| EBITDA Margin | 16.76% |
| EBIT Margin | 6.81% |
| FCF Margin | 11.21% |
Dividends & Yields
This stock pays an annual dividend of 0.70, which amounts to a dividend yield of 1.77%.
| Dividend Per Share | 0.70 |
| Dividend Yield | 1.77% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.11% |
| Shareholder Yield | 1.66% |
| Earnings Yield | 1.76% |
| FCF Yield | 4.63% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TPEX:1796 has an Altman Z-Score of 3.82 and a Piotroski F-Score of 7.
| Altman Z-Score | 3.82 |
| Piotroski F-Score | 7 |